Published • loading... • Updated
Artificial Intelligence (AI) Infrastructure Spending Is Rising. This Stock Could Benefit.
Summary by The Motley Fool
2 Articles
2 Articles
[Digital Daily Reporter Lee Anna] QAI, a quantum AI company, has selected biopharmaceutical drug development as the first commercial application area for its self-built quantum-AI hybrid data center and is promoting related services. QAI announced on the 19th that it has signed a strategic partnership with biopharmaceutical analysis company BioenSystems and will integrate BioenSystems' AI drug analysis platform into its quantum-AI hybrid infrast…
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
